Screener
United Therapeutics UTHR Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from United Therapeutics’s reported figures.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
FAQ
- What is United Therapeutics's free cash flow?
- United Therapeutics (UTHR) reported free cash flow of $205.6M in Q2 2026.
- How has United Therapeutics's free cash flow changed year-over-year?
- United Therapeutics's free cash flow increased by 58.8% year-over-year, from $129.5M to $205.6M.
- What is the long-term trend for United Therapeutics's free cash flow?
- Over 4 years (2021 to 2025), United Therapeutics's free cash flow has grown at a 21.5% compound annual growth rate (CAGR), from $477.4M to $1.04B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about United Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude